Budapest, Hungary

Gabriella Mezei

This inventor holds 1 USPTO granted patent. Top assignee: Patentbureau Danubia. Active years: 1983.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gabriella Mezei. Retrieved from https://idiyas.com/inventor/gabriella-mezei

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 1983

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Gabriella Mezei and Her Contributions to Veterinary Medicine

Introduction

Gabriella Mezei, an accomplished inventor based in Budapest, Hungary, has made significant strides in the field of veterinary medicine. With her innovative spirit, she has developed a unique patent that showcases her dedication to enhancing animal healthcare.

Latest Patents

Gabriella holds a patent for the invention of 16-amino-18,19,20-trinor-prostaglandin derivatives and their acid addition salts. This invention relates to new compounds characterized by a general formula that includes a substituted or unsubstituted phenyl group at C-17. Notably, these derivatives exhibit valuable therapeutic properties that can be utilized in cattle raising for estrus and birth synchronization. Additionally, they have applications in veterinary practice for treating conditions such as sterility, chronic endometritis, and pyometry.

Career Highlights

Gabriella is currently affiliated with Patentbureau Danubia, where her expertise continues to foster innovative solutions in veterinary medicine. Her work underscores her commitment to advancing the field and improving animal health through science and research.

Collaborations

Throughout her career, Gabriella has collaborated with esteemed colleagues, including Eva Toth-Sarudy and Gabor Ambrus. These partnerships exemplify her ability to work effectively within a team dedicated to innovation and progress in the veterinary sector.

Conclusion

In summary, Gabriella Mezei’s contributions through her patent and collaborations demonstrate her influential role in the advancement of veterinary medicine. Her innovative 16-amino-18,19,20-trinor-prostaglandin derivatives hold promise for improving the health and well-being of animals, marking her as a vital contributor to this essential field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…